ロード中...
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness
Type 2 diabetes (T2D) is a highly prevalent disorder that affects millions of people worldwide. The hallmark of T2D is hyperglycemia and, while many treatment modalities exist, achieving and maintaining glycemic control can be challenging. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are...
保存先:
| 出版年: | Ther Adv Chronic Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707429/ https://ncbi.nlm.nih.gov/pubmed/26770666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315609312 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|